Newsfeeds - Spark Newswire

1 minute read

Better Therapeutics Completes Exploratory Trial For Fatty Liver Disease And Announces Topline Results; Co. Reports ‘Study Conducted with Arizona Liver Health Met Primary Endpoint’

December 8, 8:04 AM

Study Conducted with Arizona Liver Health Met Primary Endpoint and Established Proof-of-Concept for Prescription Digital Therapy Platform to Improve Disease Biomarkers in NAFLD and NASH Patients Company Intends to Apply

BTTX

1 minute read

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday

By Lisa Levin

November 15, 8:26 AM

Chardan Capital raised PDS Biotechnology Corporation (NASDAQ:PDSB) price target from $15 to $16. . Chardan Capital analyst Geulah…

AKTS

1 minute read

Chardan Capital Maintains Buy on Better Therapeutics, Lowers Price Target to $14

By Benzinga Newsdesk

November 15, 8:02 AM

Chardan Capital analyst Keay Nakae maintains Better Therapeutics (NASDAQ:BTTX) with a Buy and lowers the price target from $17 to $14.

BTTX

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

November 14, 6:06 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

3 minute read

Better Therapeutics Highlights Publication Of BT-001 Trial In ADA Diabetes Care Journal

By Bill Haddad

October 4, 7:32 AM

)-- Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today

BTTX

1 minute read

Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes

By Vandana Singh

September 22, 9:44 AM

Better Therapeutics Inc (NASDAQ:BTTX) has submitted a de novo classification request to the FDA seeking approval for BT-001 digital therapeutic designed to…

BTTX

2 minute read

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

By Lisa Levin

September 20, 7:42 AM

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BTTX

2 minute read

Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying

By Lisa Levin

September 16, 9:14 AM

The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BLIN

5 minute read

Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

August 22, 1:02 PM

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.

ADES

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

August 11, 5:09 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG